News 15 January 2020

iCare IC200 tonometer has been granted marketing authorization in the United States

iCare IC200, the new generation tonometer for intraocular pressure screening for professional use has been cleared by FDA, the Food and Drug Administration of the United States. The product has been previously authorized in both Europe and Japan. The FDA clearance now enables the launch of sales and marketing measures also in the United States.


Welcome to learn more about iCare’s unique technology for self-monitoring of intraocular pressure

Select your country or region to continue


If your country is not listed here or you are a healthcare professional, please go to the global website

Global site